Key Highlights
- The pet healthcare market includes retail sales of worming treatments, grooming products, pet supplements, external parasite treatments, and others. The scope of others includes dog dental products, fish & rodent health care products, other cat healthcare products, other cross-segment products, and other dog healthcare products. The market is valued according to retail selling price (RSP) and includes any applicable taxes.
- The Asia-Pacific pet healthcare market recorded revenues of $3.24 billion in 2024, representing a compound annual growth rate (CAGR) of 0.5% between 2019-24.
- Market consumption volume increased with a CAGR of 2.2% between 2019-24, reaching a total of 446.4 million units in 2024.
- The Asia-Pacific pet healthcare market experienced slow growth during the review period (2019-24) due to low awareness of preventive care, limited access to veterinary services, and a fragmented informal sector that dominated much of the market.
Scope
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the pet healthcare market in Asia-Pacific
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pet healthcare market in Asia-Pacific
- Leading company profiles reveal details of key pet healthcare market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Asia-Pacific pet healthcare market with five year forecasts by both value and volume
Reasons to Buy
- What was the size of the Asia-Pacific pet healthcare market by value in 2024?
- What will be the size of the Asia-Pacific pet healthcare market in 2029?
- What factors are affecting the strength of competition in the Asia-Pacific pet healthcare market?
- How has the market performed over the last five years?
- What are the main segments that make up Asia-Pacific's pet healthcare market?
Table of Contents
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Elanco Animal Health Inc
- Boehringer Ingelheim International GmbH
- Zoetis Inc
- Virbac SA

